Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 22, 2020 08:00 ET | Source: Caladrius Biosciences, Inc.

Caladrius Biosciences to Receive $10.9 Million of Non-Dilutive Capital Through New Jersey Technology Business Tax Certificate Transfer Program

BASKING RIDGE, N.J., April 22, 2020 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (Nasdaq: CLBS) (“Caladrius” or the “Company”), today announced that it has finalized an agreement to sell $10.9...
March 05, 2020 16:05 ET | Source: Caladrius Biosciences, Inc.

Caladrius Biosciences Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Business Update

CLBS16 ESCaPE-CMD data presented at American Heart Association 2019 Scientific Sessions demonstrated highly statistically significant improvement in coronary flow reserve and angina symptoms CLBS12...
February 27, 2020 08:30 ET | Source: Caladrius Biosciences, Inc.

Caladrius Biosciences to Host Fourth Quarter and Full Year 2019 Financial Results Conference Call on Thursday, March 5, 2020 at 4:30 p.m. Eastern Time

BASKING RIDGE, N.J., Feb. 27, 2020 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (Nasdaq: CLBS) (“Caladrius” or the “Company”), a late-stage therapeutics development biopharmaceutical company...
February 03, 2020 08:30 ET | Source: Caladrius Biosciences, Inc.

Caladrius Biosciences to Participate at Upcoming February Conferences

BASKING RIDGE, N.J., Feb. 03, 2020 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (Nasdaq: CLBS) (“Caladrius” or the “Company”), a late-stage therapeutics development biopharmaceutical company...
January 07, 2020 16:05 ET | Source: Caladrius Biosciences, Inc.

Caladrius Biosciences to Participate at Upcoming January Conferences

BASKING RIDGE, N.J., Jan. 07, 2020 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (Nasdaq: CLBS) (“Caladrius” or the “Company”), a late-stage therapeutics development biopharmaceutical company...
December 02, 2019 16:05 ET | Source: Caladrius Biosciences, Inc.

Caladrius Biosciences to Participate at Upcoming December Conferences

BASKING RIDGE, N.J., Dec. 02, 2019 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (Nasdaq: CLBS) (“Caladrius” or the “Company”), a late-stage therapeutics development biopharmaceutical company...
November 16, 2019 15:59 ET | Source: Caladrius Biosciences, Inc.

Caladrius Biosciences Reports Positive Results for CLBS16 from the ESCaPE-CMD Trial at American Heart Association Scientific Sessions 2019

Single administration of CLBS16 durably improves heart function and symptoms with no cell-related adverse events CLBS16 cell therapy shows promise as a significant advancement in treatment of...
November 06, 2019 16:05 ET | Source: Caladrius Biosciences, Inc.

Caladrius Biosciences Reports 2019 Third Quarter and Nine Month Financial Results and Provides Corporate Update

BASKING RIDGE, N.J., Nov. 06, 2019 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (Nasdaq: CLBS) (“Caladrius” or the “Company”), a late-stage therapeutics development biopharmaceutical company...
October 31, 2019 08:30 ET | Source: Caladrius Biosciences, Inc.

Caladrius Biosciences to Participate at Upcoming November Conferences

BASKING RIDGE, N.J., Oct. 31, 2019 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (Nasdaq: CLBS) (“Caladrius” or the “Company”), a late-stage therapeutics development biopharmaceutical company...
October 30, 2019 08:30 ET | Source: Caladrius Biosciences, Inc.

Caladrius Biosciences to Host 2019 Third Quarter Financial Results and Business Update Conference Call on Wednesday, November 6, 2019 at 4:30 p.m. Eastern Time

BASKING RIDGE, N.J., Oct. 30, 2019 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (Nasdaq: CLBS) (“Caladrius” or the “Company”), a late-stage therapeutics development biopharmaceutical company...